parallel trade of heavily regulated medicines rather than a traditional source of arbitrage (e.g., price and income differences … medicines distribution chain regulation, and not by price differences in line with the hypothesis of ‘regulatory arbitrage’. …

able to investigate to what extent the price responsiveness of prescription choices is affected when the identity of the … are price responsive, and that the price response is considerably higher when the doctor’s affiliated hospital covers the …

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” for a sub-sample of off … group, with the effect being stronger for brand-names. We also identify a negative cross-price effect on therapeutic …

), creating a captive and a selective segment of physicians. First, we show that detailing, DTCA and price (if not regulated) are …/or price regulation is lenient. The desirability of DTCA also depends on whether or not the regulator is concerned with firms …

a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …

natural policy experiment in Norway, to what extent the price responsiveness of prescription choices is affected when the … structural model for the three drugs, covering demand and price setting, is estimated in a joint maximum likelihood approach. We …

we find that there exists a robust positive relationship between the price paid and the number of store visited. We argue …

price regulation by conforming to customers’ and authorities’ expectations. It is argued that utilities can meet …’ price setting schemes are insensitive to customer complaints, they are significantly influenced by the passive monitoring by …